Skip to Content
Merck
  • Sestrin as a feedback inhibitor of TOR that prevents age-related pathologies.

Sestrin as a feedback inhibitor of TOR that prevents age-related pathologies.

Science (New York, N.Y.) (2010-03-06)
Jun Hee Lee, Andrei V Budanov, Eek Joong Park, Ryan Birse, Teddy E Kim, Guy A Perkins, Karen Ocorr, Mark H Ellisman, Rolf Bodmer, Ethan Bier, Michael Karin
ABSTRACT

Sestrins are conserved proteins that accumulate in cells exposed to stress, potentiate adenosine monophosphate-activated protein kinase (AMPK), and inhibit activation of target of rapamycin (TOR). We show that the abundance of Drosophila sestrin (dSesn) is increased upon chronic TOR activation through accumulation of reactive oxygen species that cause activation of c-Jun amino-terminal kinase and transcription factor Forkhead box O (FoxO). Loss of dSesn resulted in age-associated pathologies including triglyceride accumulation, mitochondrial dysfunction, muscle degeneration, and cardiac malfunction, which were prevented by pharmacological activation of AMPK or inhibition of TOR. Hence, dSesn appears to be a negative feedback regulator of TOR that integrates metabolic and stress inputs and prevents pathologies caused by chronic TOR activation that may result from diminished autophagic clearance of damaged mitochondria, protein aggregates, or lipids.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Sestrin 1 human, recombinant, expressed in baculovirus infected Sf9 cells, ≥44% (SDS-PAGE)
Sigma-Aldrich
Sestrin 2 human, recombinant, expressed in baculovirus infected Sf9 cells, ≥35% (SDS-PAGE)